OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman's fertility profile by accurately measuring key hormones over time through daily urine samples. By monitoring this critical balance of hormones, OOVA can help a woman get pregnant, identify reasons she is having trouble getting pregnant, and even expose reproductive health issues like PCOS.
OOVA has raised a total of $1M in funding over 1 round. This was a Seed round raised on Mar 13, 2019.
OOVA is funded by 2 investors. Special Situations Life Sciences Innovation Fund and Company Ventures are the most recent investors.